Medpace Holdings (NASDAQ: MEDP) reported Q1 EPS of $3.20, $0.72 better than the analyst estimate of $2.48. Revenue for the quarter came in at $511 million versus the consensus estimate of $512.48 million.

GUIDANCE:

Medpace Holdings sees FY2024 EPS of $10.79-$11.47, versus the consensus of $10.70. Medpace Holdings sees FY2024 revenue of $2.15-2.2 billion, versus the consensus of $2.185 billion.

For earnings history and earnings-related data on Medpace Holdings (MEDP) click here.